120 related articles for article (PubMed ID: 11725816)
1. Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients.
Serra JA; Domínguez RO; de Lustig ES; Guareschi EM; Famulari AL; Bartolomé EL; Marschoff ER
J Neural Transm (Vienna); 2001; 108(10):1135-48. PubMed ID: 11725816
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress in Alzheimer's and vascular dementias: masking of the antioxidant profiles by a concomitant Type II diabetes mellitus condition.
Serra JA; Marschoff ER; Domínguez RO; Guareschi EM; Famulari AL; Pagano MA; de Lustig ES;
J Neurol Sci; 2004 Mar; 218(1-2):17-24. PubMed ID: 14759628
[TBL] [Abstract][Full Text] [Related]
3. The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls.
Famulari AL; Marschoff ER; Llesuy SF; Kohan S; Serra JA; Dominguez RO; Repetto M; Reides C; Sacerdote de Lustig E
J Neurol Sci; 1996 Sep; 141(1-2):69-78. PubMed ID: 8880696
[TBL] [Abstract][Full Text] [Related]
4. Systemic oxidative stress associated with the neurological diseases of aging.
Serra JA; Domínguez RO; Marschoff ER; Guareschi EM; Famulari AL; Boveris A
Neurochem Res; 2009 Dec; 34(12):2122-32. PubMed ID: 19488852
[TBL] [Abstract][Full Text] [Related]
5. Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease.
Foy CJ; Passmore AP; Vahidassr MD; Young IS; Lawson JT
QJM; 1999 Jan; 92(1):39-45. PubMed ID: 10209671
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood markers of oxidative stress in Parkinson's disease.
Younes-Mhenni S; Frih-Ayed M; Kerkeni A; Bost M; Chazot G
Eur Neurol; 2007; 58(2):78-83. PubMed ID: 17565220
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte antioxidant enzymes in Parkinson's disease.
Abraham S; Soundararajan CC; Vivekanandhan S; Behari M
Indian J Med Res; 2005 Feb; 121(2):111-5. PubMed ID: 15756044
[TBL] [Abstract][Full Text] [Related]
8. [The factors of oxidative stress in neurodegenerative diseases (vascular dementia, Alzheimer disease)].
Dubinina EE; Kovrugina SV; Konovalov PV
Adv Gerontol; 2007; 20(4):109-13. PubMed ID: 18383721
[TBL] [Abstract][Full Text] [Related]
9. Free radical toxicity and antioxidants in Parkinson's disease.
Sudha K; Rao AV; Rao S; Rao A
Neurol India; 2003 Mar; 51(1):60-2. PubMed ID: 12865518
[TBL] [Abstract][Full Text] [Related]
10. Effect of pentylenetetrazol-induced epileptic seizure on the antioxidant enzyme activities, glutathione and lipid peroxidation levels in rat erythrocytes and liver tissues.
Akbas SH; Yegin A; Ozben T
Clin Biochem; 2005 Nov; 38(11):1009-14. PubMed ID: 16122723
[TBL] [Abstract][Full Text] [Related]
11. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseases.
Sofic E; Sapcanin A; Tahirovic I; Gavrankapetanovic I; Jellinger K; Reynolds GP; Tatschner T; Riederer P
J Neural Transm Suppl; 2006; (71):39-43. PubMed ID: 17447414
[TBL] [Abstract][Full Text] [Related]
13. Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: Disease and staging biomarkers and new drug targets.
de Farias CC; Maes M; Bonifácio KL; Bortolasci CC; de Souza Nogueira A; Brinholi FF; Matsumoto AK; do Nascimento MA; de Melo LB; Nixdorf SL; Lavado EL; Moreira EG; Barbosa DS
Neurosci Lett; 2016 Mar; 617():66-71. PubMed ID: 26861200
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson's rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation.
Kuruvilla KP; Nandhu MS; Paul J; Paulose CS
J Neurol Sci; 2013 Aug; 331(1-2):31-7. PubMed ID: 23726276
[TBL] [Abstract][Full Text] [Related]
15. Plasma antioxidant status and motor features in de novo Chinese Parkinson's disease patients.
Yuan Y; Tong Q; Zhang L; Jiang S; Zhou H; Zhang R; Zhang S; Xu Q; Li D; Zhou X; Ding J; Zhang K
Int J Neurosci; 2016; 126(7):641-6. PubMed ID: 26010212
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives.
Arnal N; Cristalli DO; de Alaniz MJ; Marra CA
Brain Res; 2010 Mar; 1319():118-30. PubMed ID: 20026314
[TBL] [Abstract][Full Text] [Related]
17. No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.
Ahlskog JE; Uitti RJ; Low PA; Tyce GM; Nickander KK; Petersen RC; Kokmen E
Mov Disord; 1995 Sep; 10(5):566-73. PubMed ID: 8552107
[TBL] [Abstract][Full Text] [Related]
18. Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia.
Puertas MC; Martínez-Martos JM; Cobo MP; Carrera MP; Mayas MD; Ramírez-Expósito MJ
Exp Gerontol; 2012 Aug; 47(8):625-30. PubMed ID: 22664577
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the determination of superoxide dismutase and antioxidant capacity in neurological patients using two different procedures.
Serra JA; Marschoff ER; Domínguez RO; de Lustig ES; Famulari AL; Bartolomé EL; Guareschi EM
Clin Chim Acta; 2000 Nov; 301(1-2):87-102. PubMed ID: 11020465
[TBL] [Abstract][Full Text] [Related]
20. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
